Growth Metrics

Biogen (BIIB) Change in Acquisitions & Divestments (2016 - 2026)

Biogen has reported Change in Acquisitions & Divestments over the past 18 years, most recently at $500000.0 for Q1 2026.

  • For Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $500000.0; the TTM value through Mar 2026 reached $23.5 million, up 142.27%, while the annual FY2025 figure was $23.0 million, N/A changed from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 was $500000.0 at Biogen, up from -$33.6 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $5.7 billion in Q3 2023 and troughed at -$96.7 million in Q4 2024.
  • A 5-year average of $791.1 million and a median of $231.6 million in 2023 define the central range for Change in Acquisitions & Divestments.
  • Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 246.8% in 2023 and later tumbled 99.85% in 2024.
  • Year by year, Change in Acquisitions & Divestments stood at $566.3 million in 2022, then soared by 906.29% to $5.7 billion in 2023, then tumbled by 101.7% to -$96.7 million in 2024, then soared by 65.25% to -$33.6 million in 2025, then skyrocketed by 101.49% to $500000.0 in 2026.
  • Business Quant data shows Change in Acquisitions & Divestments for BIIB at $500000.0 in Q1 2026, -$33.6 million in Q4 2025, and $56.6 million in Q3 2025.